#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16012	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2171	734.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1483	1483	C	918	C	856	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16012	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2171	734.8	0	HET	.	.	.	C1450T	.	1450	1450	C	1749	1749	C	929	C,T	642,208	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29296	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3523	828.0	0	.	n	.	0	T695C	SNP	695	695	T	930	930	C	925	C,T	859,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29296	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3523	828.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1572	1572	A	1009	A	934	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29296	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3523	828.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2206	2206	C	926	C,T	849,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29296	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3523	828.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2280	2280	A	929	A	863	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29296	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3523	828.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2832	2832	C	888	C	831	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	20	blaTEM	861	300	99.67	blaTEM.l15.c30.ctg.1	300	3.5	0	.	p	.	0	T131S	NONSYN	391	393	ACT	52	54	AGT	3;3;3	A;G,C;T	3;0,3;3	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2146	folP	855	855	100.0	folP.l6.c4.ctg.1	1492	143.0	1	SNP	p	R229S	1	.	.	685	687	AGC	978	980	AGC	205;205;207	A;G;C	192;192;193	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6050	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3520	171.4	1	SNP	p	S91F	1	.	.	271	273	TTC	633	635	TTC	204;206;204	T,C;T;C	187,1;190;187	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6050	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3520	171.4	1	SNP	p	D95G	1	.	.	283	285	GGC	645	647	GGC	197;198;200	G;G;C	178;176;177	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6050	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3520	171.4	1	SNP	p	G95N	0	.	.	283	285	GGC	645	647	GGC	197;198;200	G;G;C	178;176;177	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1754	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1410	124.0	1	SNP	p	G45D	0	.	.	133	135	GGC	593	595	GGC	227;225;226	G;G;C	209;209;208	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	936	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	939	99.3	0	.	n	.	0	A197.	DEL	197	197	A	548	548	A	205	A	193	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5516	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2991	183.7	1	SNP	p	D86N	0	.	.	256	258	GAC	665	667	GAC	196;195;195	G;A;C	183;179;182	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5516	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2991	183.7	1	SNP	p	S87R	1	.	.	259	261	CGT	668	670	CGT	196;199;199	C;G;T	184;188;185	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5516	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2991	183.7	1	SNP	p	R87I	0	.	.	259	261	CGT	668	670	CGT	196;199;199	C;G;T	184;188;185	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5516	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2991	183.7	1	SNP	p	R87W	0	.	.	259	261	CGT	668	670	CGT	196;199;199	C;G;T	184;188;185	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5516	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2991	183.7	1	SNP	p	S88P	0	.	.	262	264	TCC	671	673	TCC	199;199;196	T;C;C	185;187;184	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4694	parE	1986	1986	100.0	parE.l6.c17.ctg.1	2510	185.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1480	1482	GGC	248;245;245	G;G;C	232;230;224	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4274	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2415	176.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1262	1264	GCA	232;231;233	G,A;C;A	206,1;211;216	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4274	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2415	176.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1265	1267	ATC	232;229;229	A;T;C	214;209;209	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4274	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2415	176.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1277	1279	GTG	241;243;243	G;T;G	214;215;215	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4274	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2415	176.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1277	1279	GTG	241;243;243	G;T;G	214;215;215	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4274	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2415	176.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1781	1783	ACC	218;220;220	A;C;C	195;198;201	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4274	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2415	176.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1835	1837	GCG	203;203;204	G;C,G;G	175;162,1;173	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4274	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2415	176.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1835	1837	GCG	203;203;204	G;C,G;G	175;162,1;173	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4274	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2415	176.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1958	1960	AGC	194;192;192	A;G;C,A	174;172;171,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4274	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2415	176.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1967	1969	GGC	177;176;175	G;G;C	162;161;160	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4274	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2415	176.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1985	1987	CCG	148;149;149	C,G;CG,CGG;G	114,1;111,1;118	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6076	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3152	192.4	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1526	1528	ACG	238;236;236	A,G;C,T;G,A	206,1;208,1;204,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6076	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3152	192.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1664	1666	CCG	215;216;215	C;C;G	188;195;187	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2426	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1738	138.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	582	582	C	174	C	164	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2814	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1587	176.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	430	432	GAA	262;264;266	G;A;A	240;243;244	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2814	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1587	176.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	718	720	GAT	232;231;232	G;A;T	217;217;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2814	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1587	176.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	841	843	TCA	236;236;237	T;C;A	214;216;218	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2814	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1587	176.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	970	972	GTC	213;213;212	G;T;C	201;201;200	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2814	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1587	176.1	0	.	p	.	0	F222S	NONSYN	664	666	TTT	982	984	TCT	224;224;227	T;C;T	207;209;211	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2814	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1587	176.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1300	1302	GCA	218;212;214	G;C;A	204;199;199	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2814	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1587	176.1	1	SNP	p	G120K	1	.	.	358	360	AAG	676	678	AAG	228;227;229	A;A;G	215;213;213	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2814	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1587	176.1	1	SNP	p	D121N	0	.	.	361	363	GAC	679	681	GAC	230;230;231	G;A;C	216;214;215	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2814	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1587	176.1	1	SNP	p	A121D	1	.	.	361	363	GAC	679	681	GAC	230;230;231	G;A;C	216;214;215	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11134	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4779	232.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1214	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1042	115.6	1	SNP	p	V57M	1	.	.	169	171	ATG	500	502	ATG	238;236;235	A,G;T;G	225,1;225;220	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
